Industry should improve the standards on application of risk management tools in light of the cases of nitrosamine impurities.
Rakesh Suman
Advertisement
Rakesh Suman is consultant at Kinapse Ltd, India.
Articles by Rakesh Suman
Advertisement
Latest Updated Articles
Nitrosamine Impurities in Medicinal ProductsPublished: December 3rd 2020 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Everything to Know About Pharmaceutical Tariffs in 2025
2
Building Resilience in Pharma: Our Top 10 Questions from CPHI Frankfurt
3
New Dosage Forms and Delivery Systems Driving 505(b)(2) Success
4
PharmTech Weekly News Roundup – Week of November 3, 2025
5
